SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Type2 Diabetes · Heart Failure With Preserved Ejection Fraction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Carolina Solis-Herrera, MD) · solisherrera@uthscsa.edu · 210-567-4800
Contact: Study coordinator (Francisca M Acosta, PhD) · acostafm@uthscsa.edu · 210-450-8677
Contact: Principal Investigator (Carolina Solis-Herrera, MD)

Study leads

Carolina Solis-Herrera, MD
Principal Investigator
The University of Texas Health Science Center at San Antonio

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission

Type2 Diabetes · Complication of Bariatric Procedure

Abroad (travel likely)Recruiting

Beijing, China

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Lancaster, United States · Lomita, United States

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

Type 2 Diabetes

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Canoga Park, United States

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Cardiovascular Autonomic Neuropathy · Type 2 Diabetes · Diabetic Neuropathies

Abroad (travel likely)RecruitingPHASE2

Gistrup, Denmark · Herlev, Denmark